Literature DB >> 12738594

The hunt for the elusive surrogate marker of sterilizing activity in tuberculosis treatment.

William J Burman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12738594     DOI： 10.1164/rccm.2302003

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  9 in total

1.  Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance.

Authors:  Tawanda Gumbo; Arnold Louie; Mark R Deziel; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 2.  Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis.

Authors:  Nicholas D Walter; Michael Strong; Robert Belknap; Diane J Ordway; Charles L Daley; Edward D Chan
Journal:  Respirology       Date:  2012-07       Impact factor: 6.424

3.  13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.

Authors:  Mandeep S Jassal; Gueno G Nedeltchev; Jong-Hee Lee; Seong Won Choi; Viorel Atudorei; Zachary D Sharp; Vojo Deretic; Graham S Timmins; William R Bishai
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

4.  Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis.

Authors:  Reynaldo Dietze; David Jamil Hadad; Bryan McGee; Lucilia Pereira Dutra Molino; Ethel Leonor Noia Maciel; Charles A Peloquin; Denise F Johnson; Sara M Debanne; Kathleen Eisenach; W Henry Boom; Moises Palaci; John L Johnson
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

5.  Peak plasma rifampicin level in tuberculosis patients with slow culture conversion.

Authors:  K-C Chang; C-C Leung; W-W Yew; K-M Kam; C-W Yip; C-H Ma; C-M Tam; E C-C Leung; W-S Law; W-M Leung
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-24       Impact factor: 3.267

6.  Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis.

Authors:  Payam Nahid; Erin Bliven-Sizemore; Leah G Jarlsberg; Mary A De Groote; John L Johnson; Grace Muzanyi; Melissa Engle; Marc Weiner; Nebojsa Janjic; David G Sterling; Urs A Ochsner
Journal:  Tuberculosis (Edinb)       Date:  2014-02-07       Impact factor: 3.131

7.  Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens.

Authors:  Nicholas D Walter; Sarah E M Born; Gregory T Robertson; Matthew Reichlen; Christian Dide-Agossou; Victoria A Ektnitphong; Karen Rossmassler; Michelle E Ramey; Allison A Bauman; Victor Ozols; Shelby C Bearrows; Gary Schoolnik; Gregory Dolganov; Benjamin Garcia; Emmanuel Musisi; William Worodria; Laurence Huang; J Lucian Davis; Nhung V Nguyen; Hung V Nguyen; Anh T V Nguyen; Ha Phan; Carol Wilusz; Brendan K Podell; N' Dira Sanoussi; Bouke C de Jong; Corinne S Merle; Dissou Affolabi; Helen McIlleron; Maria Garcia-Cremades; Ekaterina Maidji; Franceen Eshun-Wilson; Brandon Aguilar-Rodriguez; Dhuvarakesh Karthikeyan; Khisimuzi Mdluli; Cathy Bansbach; Anne J Lenaerts; Radojka M Savic; Payam Nahid; Joshua J Vásquez; Martin I Voskuil
Journal:  Nat Commun       Date:  2021-05-18       Impact factor: 14.919

8.  Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.

Authors:  Neesha Rockwood; Jotam G Pasipanodya; Paolo Denti; Frederick Sirgel; Maia Lesosky; Tawanda Gumbo; Graeme Meintjes; Helen McIlleron; Robert J Wilkinson
Journal:  Clin Infect Dis       Date:  2017-05-15       Impact factor: 9.079

9.  Bacterial load slopes represent biomarkers of tuberculosis therapy success, failure, and relapse.

Authors:  Gesham Magombedze; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Commun Biol       Date:  2021-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.